Plasminogen activator inhibitor in the blood of patients with coronary artery disease.

British medical journal (Clinical research ed.) ·Vol. 291 ·No. 6495 ·1985-08-31 ·Pages 573-4

Paramo JA, Colucci M, Collen D, van de Werf F

Abstract

暂无摘要

MeSH Terms

Adult Aged Antigens/analysis Coronary Disease/blood Female Fibrinolysis Glycoproteins/blood Humans Male Middle Aged Plasminogen Activators/antagonists & inhibitors,immunology Plasminogen Inactivators

Chemicals

Antigens Glycoproteins Plasminogen Inactivators Plasminogen Activators

Authors & Affiliations

4 authors, click to expand affiliations / ORCID

Paramo J A

Colucci M

Collen D

van de Werf F

References (4)

4 references, click to expand

Fibrinolytic activity and coronary-artery disease.
Lancet. 1968 May 11;1(7550):987-90 PMID: 4171834
Mechanisms of inhibition of tissue-type plasminogen activator in blood.
Thromb Haemost. 1983 Oct 31;50(3):678 PMID: 6417816
Plasma levels of a specific inhibitor of tissue-type plasminogen activator (and urokinase) in normal and pathological conditions.
Thromb Res. 1984 Mar 1;33(5):523-30 PMID: 6426082
Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation.
J Clin Invest. 1985 Mar;75(3):818-24 PMID: 3920245

Article Info

Journal

British medical journal (Clinical research ed.)

Abbr.

Br Med J (Clin Res Ed)

ISSN

0267-0623

DOI

10.1136/bmj.291.6495.573

Published

1985-08-31

Pages

573-4

Language

English

Region

England

NLM ID

8302911

PMCID

PMC1418240

Subset

External Links

PubMed source DOI: 10.1136/bmj.291.6495.573 PMC Full Text

Analysis Services

Plasminogen activator inhibitor in the blood of patients with coronary artery disease.

Contact

WeChat Official Account